| Device |
st2 assay |
| Regulation Description |
B-type natriuretic peptide test system. |
| Definition |
Immunoassay for the in vitro quantitative determination of soluble ST2 protein in human serum and plasma. |
| Physical State |
test reagents |
| Technical Method |
Quantitative sandwich monoclonal ELISA |
| Target Area |
In Vitro Diagnostics |
| Regulation Medical Specialty |
Clinical Chemistry |
| Review Panel |
Clinical Chemistry |
| Product Code | OYG |
| Premarket Review |
Division of Chemistry and Toxicology Devices
(DCTD)
Division of Chemistry and Toxicology Devices
(DCTD)
|
| Submission Type |
510(k)
|
| Regulation Number |
862.1117
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |